Trials / NCT03314207
Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)
Completed Observational Natural history / observational
- Sponsor
- Beacon Therapeutics
- Treatment
- Not listed
- Gene
- RPGR
- Conditions
- X-Linked Retinitis Pigmentosa
- Ages
- 6 Years to no upper limit
- Enrollment
- 14 participants
- Started
- 2017-12-01
- Main results expected
- 2022-02-10
- Results posted
- Not yet
- Record last updated
- 2023-01-11
What the study is testing
The purpose of this study is to evaluate subjects with X-linked retinitis pigmentosa caused by RPGR-ORF15 mutations in a clinical setting to fully characterize their condition, measure testing variability, and estimate rates of progression of clinical parameters.
Where it runs
United States (3)
- Duke Eye Center, Duke University Medical Center, Durham, North Carolina
- Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon
- Retina Foundation of the Southwest, Dallas, Texas